Malignant Rectal Neoplasm — Trials

Malignant Rectal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,551 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 388
Recruiting: 216
Ph III recruiting: 36
Growth YoY: +12%
Industry share: 5%
Top sponsor: Fudan University
Termination share: 28%
Trials / 1,000 deaths: 30.1 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (153)

clinicaltrialsPublishedShowing 101–150 of 341 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05201872	Bacteriological Differences Between Transanal and Laparoscopic Total Mesorectal Excision for Rectal Cancer.	unknown	—	216	Yanhong DengOTHER	1	Feb 7, 2022	clinicaltrials
NCT05201885	Oncological Differences Between Transanal and Laparoscopic Total Mesorectal Excision for Rectal Cancer.	unknown	—	192	Yanhong DengOTHER	1	Feb 3, 2022	clinicaltrials